ScholarWorks@Korea University: Kim, Yong Ku

Detailed Information

Kim, Yong Ku (김용구)

Graduate School (Department of Biomedical Sciences)

Research Area

Tel 산4930
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Depression:27||Major depressive disorder:18||Polymorphism:15||Schizophrenia:15||BDNF:14||Suicide:14||Brainderived neurotrophic factor:10||depression:9||schizophrenia:9||Cytokine:9||Bipolar disorder:8||Panic disorder:8||Serotonin:7||neuroinflammation:6||Ketamine:6||Neuroinflammation:6||Magnetic resonance imaging:5||TMS:5||Neurotrophin:5||major depressive disorder:5||ADHD:5||Alzheimer's disease:5||neuroimaging:4||Attention deficit hyperactivity disorder:4||Treatmentresistant depression:4||Cognition:4||Inflammation:4||Trauma:4||Memantine:4||Antidepressant:3||Neurodevelopment:3||neurobiology:3||polymorphism:3||Adolescent:3||MRI:3||PANSS:3||panic disorder:3||Anxiety disorders:3||Depressive disorders:3||Anxiety:3||bipolar disorder:3||Temperament:3||anxiety:3||Network analysis:3||Mental health:3||Anxiety disorder:3||Machine learning:3||efficacy:3||SLC6A2:3||Glutamate:3||NMDA receptor:3||Neuroimaging:3||antipsychotics:3||antidepressant:3||Major depression:3||suicide:3||risperidone:2||Erythropoietin:2||genetics:2||Neurogenesis:2||Treatment response:2||biomarkers:2||Insula:2||Kynurenine:2||Immune:2||Personality:2||Korean:2||Complex regional pain syndrome:2||Electroconvulsive therapy:2||Therapeutic response:2||CDSS:2||treatment:2||tolerability:2||Paradigm shift:2||Posttraumatic stress disorder:2||Predictor:2||cytokine:2||Vascular endothelial growth factor:2||Temperament and Character Inventory:2||Borna disease virus:2||NET:2||Research domain criteria (RDoC):2||Memory:2||Dimensional approach:2||Oxytocin:2||PBMCs:2||IDO:2||Neuroplasticity:2||aripiprazole:2||Major depressive disorder Remission Medication Neuropsychological function Attention Memory Executive function:2||Categorical approach:2||epigenetics:2||immune:2||Nerve growth factor:2||Agoraphobia:2||Heterogeneity:2||Stress:2||PHQ9:2||Neuroprotection:2||Gene:2||Adjustment disorder:2||GSK3 beta:2||Neuropathic pain.:2||Plasma:2||Treatmentresistant schizophrenia:2||Postpartum depression· EPDS· KEPDS· AUC.:2||Biomarker:2||microglia:2||Phenotype network:2||Treatment:2||Rat brain:2||Korea:2||review:2||Serotonin 1A receptor:2||Suicide· Tryptophan hydroxylase (TPH)· Depression· Asociation study.:2||guideline:2||children:2||Sleep:2||Psychiatric disorders:2||Prefrontal cortex:2||Tryptophan:2||Oxidative stress:2||Electroencephalography:2||Character:2||DS14:2||Antidepressants:1||generalized anxiety disorder:1||Esketamine:1||cerebrospinal fluid:1||Multicategory classification:1||GDS15:1||Medial prefrontal cortex:1||Research Domain Criteria:1||glutamate:1||postsynaptic density:1||antidepressants:1||Big data:1||Mental illness:1||Wearable device:1||Response:1||Methylation:1||Posttraurnatic symptoms:1||General working population:1||Major depressive disorder.:1||주요우울장애.:1||postmortem brain:1||Immunopharmacology:1||mRNA expression:1||IL10:1||Somatization disorder:1||Digit length ratio:1||Testosterone:1||mTOR:1||cognitive impairment:1||Interleukin10:1||IL17:1||Pharmacologically nonresponsive:1||정신과 자문·치료순응도.:1||antipsychotic:1||genegene interaction:1||Platelet:1||HTR2A:1||Tryptophan hydroxylase 2:1||Brainderived neurotrophic factor·Depression·Antidepressant:1||Inflammatory response:1||safety:1||genetic polymorphism:1||산후우울증·EPDS·KEPDS·AUC.:1||Magnetic resonance imaging (MRI):1||Graph theory:1||Social anxiety disorder:1||adolescents:1||Metabolic disorders:1||Manic symptom:1||Geriatric depression:1||default mode network:1||agoraphobia:1||FAM19A5:1||Anterior cingulate cortex:1||NMDA:1||ketamine:1||Biomarkers:1||Mobile application:1||Polymorphisms:1||apoptosis:1||Clinical efficacy:1||tryptophan catabolites:1||vascular depression:1||Kynurenine pathway:1||biopsychosocialbehavioral:1||cognitive:1||genetic:1||IFNr:1||Glutamate receptors:1||neural plasticity:1||kynurenine pathway:1||Neurodegeneration:1||Th17 cell:1||Interferongamma:1||Neurobiology:1||adolescent:1||Transforming Growth Factor beta1:1||TPH2:1||platelet:1||Tryptophan breakdown:1||Nerve growth factorbeta:1||Risperidone:1||Biological markers:1||metabolite:1||postpartum depression:1||functional MRI:1||Glial cellderived neurotrophic factor:1||Emotion regulation:1||Cognitive decline:1||s disease:1||executive control network:1||antiinflammatory interventions:1||Artificial intelligence:1||Glutamatergic system:1||Dichotomous view:1||Gaussian graphical model:1||Hypothalamicpituitaryadrenal axis:1||Autonomic nervous system:1||Allopregnanolone:1||Cognitivebehavioral therapy:1||Psychiatric diagnosis:1||Suicidal ideation:1||Bipolar disorder (BD):1||Sick leave:1||Transcranial direct current stimulation:1||TRD:1||synaptic neurotransmission of serotonin:1||selective serotonin reuptake inhibitors:1||Occupational stress:1||Eye movement desensitization reprocessing:1||Resilience:1||metabolic syndrome:1||Refractory:1||protein analysis:1||stress:1||BDNF · Neurotrophin · Panic disorder:1||Mood stabilizer:1||Bipolar:1||Insulinlike growth factor1:1||IL23:1||TCI:1||Type D personality:1||Uremia:1||Cholesterol:1||Real time RTP:1||whole blood:1||Mania:1||manic episode:1||Tryptophan hydroxylase:1||nitric oxide:1||Prognosis:1||Psychoneuroimmunology:1||아리피프라졸·정신분열병·유효성·급성기 치료.:1||mood:1||Neurotrophins:1||Neural circuit:1||Hypertension:1||Diffusion tensor imaging:1||Generalized anxiety disorder:1||posttraumatic stress disorder:1||Circadian clock:1||Mild cognitive impairment:1||Psychotic symptom:1||Operational criteria:1||A beta toxicity:1||neural biomarker:1||Prediction:1||paliperidone palmitate:1||NMethylDaspartic acid (NMDA) receptor antagonist:1||mild cognitive impairment:1||Minor depressive disorder:1||Hippocampus:1||Biopsychosocial approach:1||Integrationism:1||guidelines:1||Psychiatric disorder:1||Medication:1||Acute:1||Work place:1||Sickness absence:1||Examination Survey:1||SSRI:1||depressive disorder:1||vascular disease:1||genetic investigations:1||5HT receptors:1||polymorphisms:1||Posttraumatic growth:1||atypical antipsychotics:1||polypharmacy:1||Glucocorticoid receptor:1||autonomic nervous system:1||Interferon gamma:1||Coherence:1||Treatmentresistant:1||Kynurenic acid:1||delirium:1||DRS:1||Horses:1||stress suicide:1||blonanserin:1||cytochrome P450 3A5 (CYP3A5):1||9hydroxyrisperidone:1||pharmacogenetics:1||cytochrome P450 2D6:1||population pharmacokinetics:1||logistic regression:1||Major depressive disorder (MDD):1||antidepressant treatment:1||MEG:1||Posttraumatic stress symptoms:1||Postpartum depression:1||Separation anxiety:1||Structural neuroimaging:1||Alzheimer&#8217:1||Ising model:1||Brain magnetic resonance imaging:1||Structural covariance network:1||Prevention:1||DSM:1||Eclecticism:1||Pluralism:1||mGluR:1||Psychiatry:1||Risk factors:1||Insomnia:1||tDCS:1||Epigenetics:1||DSM5:1||lithium:1||therapeutic mechanism:1||Proinflammatory cytokines:1||Brain structure and function:1||proteomics:1||Reconsolidation:1||Valproate:1||Atomoxetine:1||Harm avoidance:1||immune system:1||뇌유래신경영양인자·신경성장인자·공황장애:1||Single nucleotide polymorphisms:1||Tumor necrosis factoralpha:1||Lorazepam:1||Diazepam:1||Gray matter:1||conscripts:1||Antipsychotics:1||MDAS:1||paliperidone:1||Glycogen synthase kinase 3 beta (GSK3 beta) gene polymorphism:1||PBMC:1||treatment response:1||Manic patients:1||Peripheral blood mononuclear cell:1||Aggression:1||Recurrence:1||ELISA:1||HTR1A:1||BDNF·우울증·항우울제:1||tryptophan hydroxylase:1||Aripiprazole· Schizophrenia· Efficacy· Acute treatment.:1||Research Domain Criteria (RDoC):1||Treatment outcome:1||EPDS:1||Thought rumination:1||Bipolar I disorder:1||White matter hyperintensity:1||Reactive astrogliosis:1||Astrocyte:1||obsessivecompulsive disorder:1||MDD:1||Cultural influences:1||Directed acyclic network:1||Subthreshold depression:1||Proinflammatory cytokines:1||Fear circuit:1||standardisation:1||Electronic health records:1||Maintenance:1||CatecholamineOmethyl transferase:1||Disaster:1||School:1||경두개 직류자극술:1||RDoC:1||risk factors:1||Pharmacogenetics:1||gene:1||NET gene:1||Emotional problems:1||Psychological tests:1||PHQ15:1||Psychiatric consultation:1||Treatment compliance.:1||TPH:1||monoamine A and B genes:1||5HT1A gene:1||Alcohols:1||cytochrome P450 2D6 (CYP2D6):1||Serotonin transporter:1||Genderdependent effect:1||Brainderived neurotropic factor:1||Gender:1||자살·트립토판 수산화 효소·우울증·연합연구.:1||양극성장애·조증·관해·인지기능·주의력·기억력·실행기능.:1||Type D Personality:1||Graph theory approach:1||CatecholOMethyltransferase:1||Aging:1||Suicidality:1||Latelife depression:1||Cortical thickness:1||Diagnostic and Statistical Manual of Mental Disorders:1||Neuropeptide Y:1||Biopsychosocialbehavioral:1||Delirium:1||Cognitive behavioral therapy for insomnia:1||Neuromodulation:1||Rating scale:1||Depressive symptoms:1||kynurenine:1||psychoneuroimmunology:1||GWAS:1||Prevalence of Depression:1||Korea National Health and Nutrition Examination Survey:1||treatment resistance:1||Kynurenine pathway metabolites:1||neural circuitry:1||lipids:1||TNFalpha:1||Glia:1||affective disorder:1||glial cell linederived neurotrophic factor:1||Single nucleotide polymorphism:1||Antipsychotic agent:1||GDNF:1||Medical students:1||Perception:1||Computerassisted signal processing:1||Internalizing problem:1||Embitterment:1||PTED:1||Atypical feature:1||rTMS:1||50C/T:1||Hypothalamicpituitaryadrenal:1||Jockeys:1||transforming growth factorbeta1:1||CatecholOmethyltransferase (COMT):1||Environment:1||Realtime reverse transcriptase polymerase chain reaction:1||Hopelessness:1||Alcohol dependence:1||longterm treatment:1||Edinburgh Postnatal Depression Scale:1||predictor:1||Wisconsin Card Sorting Test:1||IL2:1||mania:1||Coronary Disease:1||Resting state functional connectivity:1||Brain connectome:1||Suicide attempt:1||biomarker:1||Depressive disorder:1||Anhedonia:1||latelife depression:1||dementia:1||restingstate functional magnetic resonance imaging:1||salience network:1||CREB:1||cariprazine:1||plasma:1||Synaptic plasticity:1||Amygdala:1||Hydrocortisone:1||reliability:1||validity:1||Internet:1||Lithium:1||TrkB:1||Job stress:1||Korea National Health and Nutrition:1||research domain criteria:1||serotonin:1||psychoimmunology:1||Serotonin receptors:1||major depression:1||Dentist:1||General Population:1||Posttraumatic stress disorders:1||5HT2A receptor:1||5HT3A receptor:1||model:1||neurodevelopment:1||neurochemistry:1||Methylphenidate:1||endocrine:1||Antioxidants:1||neuropsychology:1||Voxelbased morphometry:1||Power:1||personality:1||Glycogen synthase kinase:1||Hemodialysis:1||3Hydroxykynurenine:1||1727A/T:1||mRNA:1||restless legs syndrome:1||Association:1||Impulsiveness:1||Serotonin 2A receptor:1||serotonin 2A receptor:1||Risk factor:1||female sexual arousal:1||IL4:1||Bipolar disorder·Manic·Remission·Cognition·Attention·Memory·Neuropsychology.:1||gut microbiota:1||Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM5):1||Reward processing:1||Brain structural covariance network:1||brainderived neurotrophic factor:1||Posttraumatic stress disorder:1||melatonin:1||Obsessivecompulsive disorder:1||Metabolomics:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE